From: Tolerability of MenACWY-TT vaccination in adolescents in the Netherlands; a cross-sectional study
Swelling | Redness | Pain | Swelling armpit | Reduced use of arm | |
---|---|---|---|---|---|
Severity (n; %) | |||||
None | 101 (93.5) | 104 (96.3) | 54 (50.0) | 105 (97.2) | 85 (78.7) |
< 2.5 cm / mild | 7 (6.5) | 3 (2.8) | 32 (29.6) | 1 (0.9) | 15 (13.9) |
2.5–5 cm / moderate | 0 (−) | 1 (0.9) | 19 (17.6) | 2 (1.9) | 5 (4.6) |
> 5 cm / pronounced | 0 (−) | 0 (−) | 3 (2.8) | 0 (−) | 3 (2.8) |
Recovered (% yes) | 7 (100) | 4 (100) | 52 (96.3) | 3 (100) | 23 (100) |
Mean onset time in hr. (sd; range) | 1.1 (1.1; 0.05–3.0) | 1.3 (1.4; 0.03–3.0) | 2.0 (5.5; 0.0–24) | 18.3 (9.8; 7.0–24) | 7.1 (10.3; 0.0–24) |
Mean duration in hr. (sd; range) | 40.1 (38.5; 5.0–120) | 42.1 (35.8; 0.5–72) | 55.6 (35.9; 0.0–144) | 56.0 (13.9; 48–72) | 55.0 (32.2; 0.0–120) |